SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 86 filers reported holding SERES THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $26,095 | -72.5% | 18,639 | -53.3% | 0.00% | – |
Q3 2023 | $95,048 | -50.3% | 39,936 | 0.0% | 0.00% | – |
Q2 2023 | $191,293 | +17.9% | 39,936 | +39.5% | 0.00% | – |
Q1 2023 | $162,315 | +1.3% | 28,627 | 0.0% | 0.00% | – |
Q4 2022 | $160,311 | -20.3% | 28,627 | -8.6% | 0.00% | – |
Q3 2022 | $201,036 | +80.4% | 31,314 | -3.6% | 0.00% | – |
Q2 2022 | $111,448 | -47.8% | 32,492 | +8.4% | 0.00% | – |
Q1 2022 | $213,429 | -30.7% | 29,976 | -19.0% | 0.00% | – |
Q4 2021 | $308,000 | +16.7% | 37,022 | -2.5% | 0.00% | – |
Q3 2021 | $264,000 | -71.9% | 37,973 | -3.8% | 0.00% | -100.0% |
Q2 2021 | $941,000 | +45.2% | 39,458 | +25.3% | 0.00% | 0.0% |
Q1 2021 | $648,000 | -20.5% | 31,479 | -5.4% | 0.00% | 0.0% |
Q4 2020 | $815,000 | -6.0% | 33,284 | +8.7% | 0.00% | 0.0% |
Q3 2020 | $867,000 | +561.8% | 30,610 | +8.7% | 0.00% | – |
Q2 2020 | $131,000 | +36.5% | 28,158 | +4.6% | 0.00% | – |
Q1 2020 | $96,000 | +10.3% | 26,925 | +7.2% | 0.00% | – |
Q4 2019 | $87,000 | -7.4% | 25,123 | +5.0% | 0.00% | – |
Q3 2019 | $94,000 | -45.0% | 23,921 | +19.9% | 0.00% | – |
Q2 2018 | $171,000 | +31.5% | 19,943 | +11.7% | 0.00% | – |
Q1 2018 | $130,000 | -27.0% | 17,849 | +1.0% | 0.00% | – |
Q4 2017 | $178,000 | -34.8% | 17,679 | +3.7% | 0.00% | – |
Q3 2017 | $273,000 | +32.5% | 17,042 | -6.7% | 0.00% | – |
Q2 2017 | $206,000 | +15.7% | 18,270 | +15.2% | 0.00% | – |
Q1 2017 | $178,000 | +27.1% | 15,860 | +11.5% | 0.00% | – |
Q4 2016 | $140,000 | -18.1% | 14,220 | +2.1% | 0.00% | – |
Q3 2016 | $171,000 | -55.1% | 13,921 | +6.2% | 0.00% | -100.0% |
Q2 2016 | $381,000 | +136.6% | 13,103 | +104.7% | 0.00% | – |
Q1 2016 | $161,000 | +172.9% | 6,400 | +280.7% | 0.00% | – |
Q4 2015 | $59,000 | +1080.0% | 1,681 | +849.7% | 0.00% | – |
Q3 2015 | $5,000 | – | 177 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $148,411,000 | 6.25% |
Eversept Partners, LP | 1,935,825 | $12,427,997 | 1.08% |
Kynam Capital Management, LP | 772,820 | $4,962,000 | 1.05% |
SILVERARC CAPITAL MANAGEMENT, LLC | 366,493 | $2,353,000 | 0.80% |
Lion Point Capital, LP | 626,803 | $3,228,000 | 0.71% |
FEDERATED HERMES, INC. | 18,499,136 | $118,765,000 | 0.35% |
Knott David M Jr | 110,000 | $706,000 | 0.30% |
Atom Investors LP | 108,820 | $699,000 | 0.25% |
Ikarian Capital, LLC | 131,310 | $843,000 | 0.17% |
HARVARD MANAGEMENT CO INC | 131,847 | $846,000 | 0.10% |